In this case-control study of a Chinese population, we found novel associations between CAD development and methylation levels of the CDKN2B-AS1 (ANRIL) promoter region CpG sites, which were significantly correlated with blood glucose and cholesterol levels, respectively. The gene discussed is CDKN2B-AS1; the disease is coronary artery disorder.